Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-04 Option Award |
2025-04-10 4:50 pm |
N/A N/A |
AGENUS INC | AGEN | Buell Jennifer Director |
1,159 | $1.56 | 18,288 (Direct) |
View |
2025-03-21 Option Award |
2025-03-27 4:05 pm |
N/A N/A |
AGENUS INC | AGEN | Buell Jennifer Director |
1,123 | $1.61 | 17,129 (Direct) |
View |
2025-03-07 Option Award |
2025-03-24 4:05 pm |
N/A N/A |
AGENUS INC | AGEN | Buell Jennifer Director |
409 | $2.35 | 15,646 (Direct) |
View |
2025-02-21 Option Award |
2025-03-11 4:05 pm |
N/A N/A |
AGENUS INC | AGEN | Buell Jennifer Director |
545 | $3.32 | 15,237 (Direct) |
View |
2025-02-21 Option Award |
2025-03-05 4:05 pm |
N/A N/A |
AGENUS INC | AGEN | Buell Jennifer Director |
626 | $3.32 | 15,318 (Direct) |
View |
2025-02-07 Option Award |
2025-02-18 4:05 pm |
N/A N/A |
AGENUS INC | AGEN | Buell Jennifer Director |
516 | $3.5 | 14,692 (Direct) |
View |
2025-01-24 Tax Withholding |
2025-02-04 4:05 pm |
N/A N/A |
AGENUS INC | AGEN | Buell Jennifer Director |
270 | $3.57 | 14,176 (Direct) |
View |
2025-01-24 Option Award |
2025-01-28 6:22 pm |
N/A N/A |
AGENUS INC | AGEN | Buell Jennifer Director |
776 | $3.57 | 14,446 (Direct) |
View |
2024-11-14 Option Award |
2024-11-18 4:05 pm |
N/A 2034-11-14 |
AGENUS INC | AGEN | Buell Jennifer Chairman Executive Council |
300,000 | $0 | 300,000 (Direct) |
View |
Ownership |
2024-06-20 4:05 pm |
N/A N/A |
AGENUS INC | AGEN | Buell Jennifer Chairman Executive Council |
0 | $0 | 246,168 (Direct) |
View |
2024-03-25 Option Award |
2024-03-29 9:29 pm |
N/A 2034-03-25 |
Protagenic Therapeutics Inc. | PTIX | Buell Jennifer Director |
75,000 | $1.74 | 75,000 (Direct) |
View |
2024-01-16 Option Award |
2024-01-18 8:00 pm |
N/A 2034-01-16 |
MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer |
1,160,919 | $0 | 1,160,919 (Direct) |
View |
2023-10-11 Option Award |
2023-10-13 8:18 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer |
695,750 | $0 | 927,915 (Direct) |
View |
2023-10-11 Other |
2023-10-13 8:18 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer |
695,750 | $0 | 927,915 (Direct) |
View |
2023-10-02 Tax Withholding |
2023-10-03 9:15 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer |
58,550 | $1.0445 | 927,915 (Direct) |
View |
2023-09-29 Tax Withholding |
2023-10-03 9:15 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer |
25,000 | $1.1538 | 927,915 (Direct) |
View |
2023-10-03 Tax Withholding |
2023-10-03 9:15 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer |
65,000 | $0.9449 | 927,915 (Direct) |
View |
2023-09-27 Exercise |
2023-09-29 4:30 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer |
695,750 | $0 | 1,772,215 (Direct) |
View |
2023-01-09 Option Award |
2023-01-11 4:58 pm |
N/A 2033-01-09 |
MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer |
500,000 | $0 | 880,715 (Direct) |
View |
2023-01-09 Option Award |
2023-01-11 4:58 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | Buell Jennifer Chief Executive Officer |
171,990 | $2.32 | 880,715 (Direct) |
View |
2022-01-21 Option Award |
2022-01-25 5:20 pm |
N/A 2032-01-21 |
MiNK Therapeutics Inc. | INKT | Buell Jennifer See Remarks |
679,800 | $0 | 679,800 (Direct) |
View |
Ownership |
2021-10-20 6:53 pm |
N/A N/A |
MiNK Therapeutics Inc. | INKT | Buell Jennifer See Remarks |
0 | $0 | 1,808,950 (Direct) |
View |
2021-06-15 Option Award |
2021-07-02 7:34 pm |
N/A 2030-12-17 |
AGENUS INC | AGEN | Buell Jennifer COO and President |
900,000 | $0 | 1,027,091 (Direct) |
View |
2021-06-30 Option Award |
2021-07-02 7:34 pm |
N/A N/A |
AGENUS INC | AGEN | Buell Jennifer COO and President |
10,597 | $5.49 | 1,027,091 (Direct) |
View |
2021-04-02 Option Award |
2021-04-05 09:06 am |
N/A N/A |
AGENUS INC | AGEN | Buell Jennifer President & COO |
80,838 | $2.87 | 116,494 (Direct) |
View |
2020-12-17 Option Award |
2020-12-21 12:41 pm |
N/A 2030-12-17 |
AGENUS INC | AGEN | Buell Jennifer COO and President |
900,000 | $0 | 900,000 (Direct) |
View |
2020-07-18 Option Award |
2020-07-21 5:06 pm |
2020-07-18 2030-07-18 |
Protagenic Therapeutics Inc. | PTIX | Buell Jennifer Director |
145,000 | $1.75 | 145,000 (Direct) |
View |
2020-06-15 Option Award |
2020-06-17 4:01 pm |
N/A 2030-06-15 |
AGENUS INC | AGEN | Buell Jennifer COO and President |
10,000 | $0 | 10,000 (Direct) |
View |